Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 8/20/20 → 1/12/24 |
Financiación
- Sanofi Aventis US Inc: 13.631,00 US$
EFC16034: A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio) in participants with relapsing forms of multiple sclerosis (GEMINI 2)
- Avasarala, Jagannadha (PI)
- Chalkley, Joshua (CoI)